Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
A comprehensive review study has found that Medicaid and commercial insurance coverage policies for Biogen Alzheimer’s disease drug, Aduhelm, showed large inconsistencies based on plan and geography.
Tufts MC's Predictive Analytics and Comparative Effectiveness (PACE) Center the Recipient of National Institute of Neurological Disorders and Stroke (NINDS) Grant.
In order to further strengthen the connection between the MIRI and investigators involved in complementary work across Tufts Medicine and Tufts University, MIRI created the role of "Associate PI."
While there are different types of varicose veins, there are also different methods for treating them — each unique the patient’s situation and lifestyle.
A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.
The Reid R. Sacco Adolescent & Young Adult (AYA) Cancer Program at Tufts Medical Center was created 7 years ago and the team has shared the creation and model of care in a recent publication.
Dr. Elizabeth Yen, a neonatologist at Tufts Medical Center, has joined as PI. Dr. Yen’s lab conducts non-invasive salivary transcriptomic and brain magnetic imaging studies to understand the impact of the prenatal opioid exposure on the developing brain.